Doliprane 1000mg paracetamol

Doliprane is a leading paracetamol-based medication used for pain and fever relief. Originally launched in France by the pharmaceutical firm Bottu, the brand has become one of the most recognized consumer healthcare names in the French pharmaceutical market.

Manufacturing for Doliprane is predominantly centered in Lisieux, France, where Sanofi maintains extensive production facilities. For decades, Doliprane has been owned by the French multinational Sanofi. However, following strategic realignments, Sanofi transitioned the brand under Opella, its dedicated consumer healthcare business unit. In late 2024, Sanofi announced definitive plans to enter negotiations to sell a controlling stake in Opella to the American private equity firm Clayton, Dubilier & Rice (CD&R), marking a historic shift in the brand's ultimate ownership and investment structure while maintaining significant operational presence in its country of origin.